Near future—Targeting Aging with Metformin (TAME) Trial

This clinical trial, designed to test the hypothesis that the diabetes drug metformin can delay the onset of age-related disease, is the first clinical trial designed to target mechanisms of aging instead of a specific age-related condition. It aims to test 3,000 people aged 65-79 in 14 separate centers over 6 years to compare a wide range of health metrics between participants taking and not taking metformin.

Leave a Comment